Generex Biotechnology Corp.
33 Harbour Square
Suite 202
Toronto,
ON M5J 2G2
Canada - Map
Phone: 416-364-2551
Fax: 416-364-9363
Web Site: http://www.generex.com
| Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The companys products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporations under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada. |
|
| Key Statistics |
| |
| | Pay | Exercised | Ms. Anna E. Gluskin , 59
Chairperson, Chief Exec. Officer and Pres |
N/A
| N/A | Ms. Rose C. Perri , 43
Chief Financial & Operating Officer, Principal Accounting Officer, Sec., Treasurer |
N/A
| N/A | Mr. Mark A. Fletcher Esquire, 44
Exec. VP and Gen. Counsel |
N/A
| N/A | Dr. Eric Von Hofe Ph.D,
Pres of Antigen Express |
N/A
| N/A | Mr. Minzhen Xu MD, PhD,
Chief Experimentalist and VP of Biology - Antigen Express Inc |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.17% Nasdaq 
Profile
